Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine versus morphine + diazepam versus morphine + methocarbamol for pain control in spinal trauma
IRCT20130108012072N12Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Spinal cord injury (SCI) comparing Morphine, Morphine + diazepam and Morphine + methocarbamol (3 arms). Primary endpoints: Pain control efficacy and Pain severity over time. Started Dec 2020; status: completed.
02
Drugs
morphinediazepammethocarbamol
03
Conditions
Spinal cord injury (SCI)
Beyond the preview
Go deeper on IRCT20130108012072N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130108012072N12.